Core Viewpoint - The stock of Kefu Medical (301087) shows a slight increase in price and a mixed flow of funds, indicating a stable performance in the market despite some outflows from retail investors [1][2]. Group 1: Stock Performance - As of February 6, 2026, Kefu Medical's stock closed at 54.47 yuan, with a 0.15% increase and a turnover rate of 1.51% [1]. - The trading volume was 29,400 hands, with a total transaction amount of 160 million yuan [1]. Group 2: Fund Flow Analysis - On February 6, 2026, the net inflow of main funds was 7.80 million yuan, accounting for 4.87% of the total transaction amount [1]. - Retail investors experienced a net outflow of 3.20 million yuan, representing 2.0% of the total transaction amount [1]. - The outflow from speculative funds was 4.60 million yuan, making up 2.87% of the total transaction amount [1]. Group 3: Financial Performance - For the first three quarters of 2025, Kefu Medical reported a main revenue of 2.398 billion yuan, a year-on-year increase of 6.63% [2]. - The net profit attributable to the parent company was 260 million yuan, up 3.3% year-on-year [2]. - The third quarter of 2025 saw a significant increase in revenue, reaching 902 million yuan, which is a 30.72% year-on-year growth [2]. - The net profit for the third quarter was approximately 92.83 million yuan, reflecting a 38.68% increase year-on-year [2]. - The company’s gross profit margin stood at 53.35% [2]. Group 4: Institutional Ratings - In the last 90 days, five institutions provided ratings for Kefu Medical, with four giving a "buy" rating and one an "increase" rating [2]. - The average target price set by institutions over the past 90 days is 54.92 yuan [2].
股票行情快报：可孚医疗（301087）2月6日主力资金净买入780.37万元